Crestwood Advisors Group’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Crestwood Advisors Group’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-25,000	Closed	-$164K	–	247
2020 Q2	$164K	Sell	25,000 -5,000	-17%	-$27.9K	0.01%	227
2020 Q1	$153K	Sell	30,000 -37,000	-55%	-$224K	0.01%	212
2019 Q4	$514K	Sell	67,000 -15,571	-19%	-$90.9K	0.02%	176
2019 Q3	$438K	Hold	82,571	–	–	0.02%	175
2019 Q2	$462K	Buy	+82,571	New	+$340K	0.02%	173
2017 Q2	–	Sell	-5,000	Closed	-$22K	–	451
2017 Q1	$22K	Hold	5,000	–	–	﹤0.01%	367
2016 Q4	$11K	Hold	5,000	–	–	﹤0.01%	163
2016 Q3	$15K	Hold	5,000	–	–	﹤0.01%	128
2016 Q2	$13K	Buy	5,000 +1,429	+40%	+$3.98K	﹤0.01%	133
2016 Q1	$11K	Buy	+3,571	New	+$19.1K	﹤0.01%	139

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ICM

ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PCM

Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Crestwood Advisors Group's CDMO Position: Q3 2020 in Review

Crestwood Advisors Group sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q3 2020, closing a stake of 25,000 shares — an estimated $164K sold.

Crestwood Advisors Group first reported a position in CDMO in Q1 2016 and held it in 10 quarters. The position peaked at $514K in Q4 2019. 111 funds tracked by Wall St. Rank hold CDMO as of Q3 2020.

Crestwood Advisors Group reported no remaining Avid Bioservices, Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
Crestwood Advisors Group sold 25,000 Avid Bioservices, Inc. Common Stock shares in Q3 2020, an estimated $164K.
Crestwood Advisors Group first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2016 and held it in 10 quarters.
Crestwood Advisors Group's Avid Bioservices, Inc. Common Stock position peaked at $514K in Q4 2019.
111 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q3 2020.

Based on Crestwood Advisors Group's 13F filing for Q3 2020, filed 6 Oct 2020.